During 2020, Central America's imports of pharmaceutical products containing insulin totaled $35 million, and purchases from Danish companies increased 11% over what was reported in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
During 2020, companies in the region allocated $134 million for the import of vaccines for human use, and purchases from Russian companies increased 54% over what was reported in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]
The Guatemalan Institute of Social Security bids CT scan services for patients of the institution, who are treated at the General Hospital of Quetzaltenango.
Agencia Farmaceutica S.A., Corporacion Impa Doel S.A., Hispomedica SRL and Cefa Central Farmaceutica are among the companies that won contracts last year to supply medicines and pharmaceutical products to public health institutions in the region.
An analysis by CentralAmericaData's Business Intelligence department provides interesting data on the companies that in 2020 were awarded contracts to supply pharmaceutical products and medical supplies to the different Ministries of Health and Social Security entities in Central American countries and the Dominican Republic.
In the Dominican Republic, the supply of parenteral and enteral nutrition for patients in hospitals belonging to the single public network of health services is tendered for a period of 12 months according to daily and personalized requirements.
In the Dominican Republic, the supply of medicines and medical sanitary inputs is being tendered, which will be used to mitigate the spread of covid-19.
In the case of Costa Rica, a potential for internationalization has been identified in five medical service specialties: orthopedics, fertility, oncology, ophthalmology and bariatric surgery.
A study carried out by the Promotora de Comercio Exterior (Procomer) states that "On a general level of context, it was determined that in all of them (with the exception of fertility) there is evidence of experience in the care of international patients (at least in one procedure)."
In this context of crisis, El Salvador's pharmaceutical sector is one of the few that managed to increase its exports in the first half of the year, and in some cases production plants have had to work double shifts to meet demand.
The manufacture of pharmaceuticals, medicinal chemicals and pharmaceutical botanicals was one of the few sectors that, from January to June 2020, registered a positive variation in the amount of its sales abroad, according to official data from the Central Reserve Bank.
Productos Roche, Drogueria e Importadora Alemana and Corporacion Industrial Farmaceutica are some of the companies that during the first six months of the year won contracts to provide medicines and pharmaceutical products to public health institutions in the region.
The "Interactive Public Procurement Information System" of CentralAmericaData's Trade Intelligence Unit provides interesting data on the companies that in the first half of 2020 were favored with contracts to provide pharmaceutical products and medical supplies to the various Ministries of Health and Social Security entities in the Central American countries.
The U.S. International Development Finance Corporation offered a $250 million quota for companies in the country to invest in health sector projects.
Directors of the International Development Finance Corporation (DFC) were the ones who reported last May 11 the existence of these financial resources. The exclusivity of these $250 million for companies in the health sector is due to the current health emergency situation, which derives from the outbreak of covid-19.
español
2857
